Literature DB >> 90165

Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis.

P K Weck, A R Carroll, D M Shattuck, R R Wagner.   

Abstract

UV irradiation of infectious vesicular stomatitis virus was employed to study the relationship between the expression of certain viral gene functions and viral inhibition of RNA synthesis in mouse myeloma (MPC-11) cells. Viral infectivity, protein synthesis, and viral mRNA synthesis were all highly susceptible to inactivation by UV radiation; however, low levels of viral transcriptase activity were detected in vitro in virus preparations subjected to large doses of UV radiation. In sharp contrast, the capacity of vesicular stomatitis virus to shut off cellular transcription was quite resistant to UV radiation. The data presented here indicate that viral transcription is essential to inhibit host RNA metabolism, even though synthesis of viral polypeptides in the inhibited cells could not be detected. At those levels of UV radiation that inactivated all viral gene functions, except viral inhibition of cellular RNA synthesis, the only viral product detected was non-adenylated, low-molecular-weight RNA species.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90165      PMCID: PMC353383          DOI: 10.1128/JVI.30.3.746-753.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  BIOLOGIC PROPERTIES OF TWO PLAQUE VARIANTS OF VESICULAR STOMATITIS VIRUS (INDIANA SEROTYPE).

Authors:  R R WAGNER; A H LEVEY; R M SNYDER; G A RATCLIFF; D F HYATT
Journal:  J Immunol       Date:  1963-07       Impact factor: 5.422

2.  Cell killing by viruses. II. Cell killing by vesicular stomatitis virus: a requirement for virion-derived transcription.

Authors:  P I Marcus; M J Sekellick
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

3.  Method of examining viral RNA metabolism in cells in culture: metabolism of vesicular stomatitis virus RNA.

Authors:  G W Wertz
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

4.  Sequential transcription of the genes of vesicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

5.  Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  P E McAllister; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

6.  Mapping and initiation studies on the leader RNA of vesicular stomatitis virus.

Authors:  R J Colonno; A K Banerjee
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

7.  Cell killing by viruses. V. Transcribing defective interfering particles of vesicular stomatitis virus function as cell-killing particles.

Authors:  P I Marcus; M J Sekellick; L D Johnson; R A Lazzarini
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

8.  Mechansims of vesicular stomatitis virus-induced cytopathic effects. II. Inhibition of macromolecular synthesis induced by infectious and defective-interfering particles.

Authors:  B Baxt; R Bablanian
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

9.  Order of transcription of genes of vesicular stomatitis virus.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation.

Authors:  E J Dubovi; R R Wagner
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

View more
  21 in total

1.  Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins.

Authors:  D E Crone; J D Keene
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

2.  Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding.

Authors:  B W Grinnell; R R Wagner
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

3.  The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.

Authors:  B L Black; R B Rhodes; M McKenzie; D S Lyles
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA.

Authors:  B W Grinnell; R R Wagner
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

Review 5.  The genetics of vesiculoviruses.

Authors:  C R Pringle
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Nucleotide sequence and host La protein interactions of rabies virus leader RNA.

Authors:  M G Kurilla; C D Cabradilla; B P Holloway; J D Keene
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Infection of Melanoplus sanguinipes grasshoppers following ingestion of rangeland plant species harboring vesicular stomatitis virus.

Authors:  Barbara S Drolet; Melissa A Stuart; Justin D Derner
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

8.  Novel phenotype of RNA synthesis expressed by vesicular stomatitis virus isolated from persistent infection.

Authors:  T K Frey; J S Youngner
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Rapid and transient localization of the leader RNA of vesicular stomatitis virus in the nuclei of infected cells.

Authors:  M G Kurilla; H Piwnica-Worms; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Inhibition of cellular DNA synthesis by vesicular stomatitis virus.

Authors:  J J McGowan; R R Wagner
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.